Wesfarmers (ASX: WES) — Investment Research Report

3-Year / 5-Year Price Scenarios

Base EPS: $2.7 — TTM EPS is FY2025 basic EPS A$2.58 less FY2025 first-half EPS A$1.294 plus FY2026 first-half EPS A$1.414. The calculation is analyst-derived from the two official reports, not company guidance.

0. Information Richness & AI Limitations

Grade A (rich public information). Wesfarmers publishes detailed annual and half-year reporting, segment KPIs and governance material. This is confidence in the evidence base, not certainty about future returns. The central uncertainty is valuation: a high-quality business can still be a poor purchase when expectations are already embedded in the price. Results-calendar evidence: Wesfarmers Investor Centre, accessed 2026-07-31.

1. Data & Cross-Validation

The ASX company header reported WES at A$88.89 and market capitalisation of A$101.29B on the 2026-07-31 cutoff. Implied shares are approximately 1,139.5M (A$101.29B / A$88.89), reconciling the reported market cap by construction. TTM EPS of A$2.70 is calculated from official FY2025 and 2026 half-year reports; it implies 32.9x TTM earnings. The ordinary FY2025 dividend was A$2.06 per share; the A$1.50 capital-management distribution is excluded from recurring yield.

Primary financials (AUD): FY2025 revenue A$45.700B and attributable NPAT A$2.926B; FY2026 first-half revenue A$24.212B and attributable NPAT A$1.603B. Basic EPS was A$2.58 for FY2025 and A$1.414 for the 2026 half-year, with the interim dividend A$1.02. Sources: Wesfarmers 2025 Full-year results and 2026 Half-year Report, direct URLs recorded in research_evidence.

Cross-check: the ASX header’s A$101.29B market cap divided by A$88.89 equals approximately 1.1395B shares. Competitor header snapshots were BWP A$3.91, Woolworths A$39.77 and Coles A$24.10; these are context only, not like-for-like valuations.

2. Business Essence — Duan Yongping

One line: Wesfarmers is a portfolio of trusted, scaled Australian customer franchises, with Bunnings and Kmart converting buying scale, private brands and store networks into recurring traffic and high returns.

Bunnings solves frequent home-improvement and trade needs; Kmart solves value-focused general merchandise; Priceline and Officeworks add health and office ecosystems. Retail is not subscription revenue, but habit, convenience, assortment and trust produce repeat economics. Scale improves procurement, private-label economics, distribution and advertising/data leverage. Wesfarmers can redeploy cash into existing franchises or incubate adjacent platforms, though chemicals and health are more cyclical or execution-dependent.

3. Moat — Buffett

The strongest moats are scale and cost position (Bunnings and Kmart), brand and trust, store density and distribution, private-label product capability, and accumulated customer/data assets. Bunnings’ trade relationships and range depth are difficult to replicate; Kmart’s Anko value proposition combines sourcing scale with a recognisable brand. Switching costs are modest at the individual transaction level, so the moat depends on habit, price leadership and execution rather than lock-in.

The moat is durable but not invulnerable. Amazon and specialist digital competitors can attack assortment; Costco, independent trade and discount chains can attack price; housing cycles affect Bunnings demand. The moat is widening when scale funds lower prices and better range, and narrowing if stores become less productive or cost inflation is passed through poorly.

4. Reverse Thinking & Risks — Munger

The inversion is simple: the investment loses even if the franchises remain good when earnings merely stagnate and the multiple normalises. Historical analogies include high-quality retailers that suffered long valuation drawdowns after a single margin or comparable-sales disappointment. Disconfirming evidence would be sustained share gains, stable margins and strong cash conversion through a weak consumer cycle.

5. Management — Duan Yongping + Buffett

Wesfarmers has a long record of decentralised operating accountability, disciplined portfolio review and returning capital when opportunities are limited. The FY2025 report shows ordinary dividends of A$2.06 per share and a separate proposed A$1.50 capital-management distribution, illustrating willingness to return excess capital rather than automatically empire-build. Management’s challenge is to keep reinvesting at high incremental returns while funding health, lithium and industrial transitions.

The governance test is whether capital is allocated to the best franchise rather than the most exciting narrative. The evidence supports a strong but not infallible record; the principal uncertainty is the return profile of newer growth initiatives.

6. Industry & Civilizational Trend — Li Lu

Wesfarmers sits at the consumer-distribution layer of the Australian economy. Retail TAM is mature, but housing maintenance, trade activity, value-seeking, healthcare consumption and omnichannel adoption provide continuing demand. Technology is an efficiency tool and a competitive threat: data, digital fulfilment, automation and private-label design can widen scale advantages, while marketplaces and direct-to-consumer brands reduce distribution friction.

The portfolio’s long-run opportunity is therefore productivity and share gain, not unlimited market expansion. Bunnings and Kmart are closer to enduring consumer infrastructure than to a short-lived technology story; lithium and chemicals add optionality but also cyclicality.

7. Valuation & Scenarios — Buffett + Duan

At A$88.89 and analyst-derived TTM EPS of A$2.70, WES trades at 32.9x earnings. The valuation assumes continued Bunnings/Kmart execution, reasonable Health progress and a premium for franchise quality. The scenario model uses EPS compounding and an exit P/E, not a claim of precision.

Three-year: Bull 8% EPS growth and 34x = A$115.64 (+30.1%, 25% probability); base 5% and 28x = A$87.52 (−1.6%, 55%); bear −2% and 22x = A$55.91 (−37.1%, 20%). Weighted target is A$88.23 (−0.75%).

Five-year: Bull 8% and 34x = A$134.88 (+51.7%, 25%); base 4% and 28x = A$91.98 (+3.5%, 55%); bear −2% and 20x = A$48.81 (−45.1%, 20%). Weighted target is A$94.07 (+5.83%) before dividends. The key uncertainty is the terminal multiple: a 4–5 percentage-point change in P/E matters more than small changes in near-term sales growth.

8. Decision Memo

Decision: Hold rather than chase. A buy zone of A$70–78 would provide a more defensible entry multiple if franchise economics remain intact. Add on evidence of sustained Bunnings/Kmart share and margin gains, or a valuation reset without thesis damage. Sell or reduce if core retail loses its cost/brand advantage, Health absorbs capital without progress, or leverage and acquisition risk rise. The thesis is invalidated by persistent comparable-sales and EBIT deterioration, not by one noisy quarter.

Four-Master Commentary

The following are analytical simulations, not real quotations.

Buffett: A portfolio of understandable consumer franchises with scale advantages is attractive, but the purchase price must leave room for error. Bunnings and Kmart deserve quality premiums; 33x earnings leaves little room for a bad cycle.

Munger: Invert it. The easiest way to lose money is to confuse a wonderful business with a wonderful investment at any price. Ask what happens when margins flatten and the multiple falls.

Duan Yongping: The best assets are businesses customers return to and competitors struggle to copy. I would prefer to own more when the price offers a margin of safety, not when the story is most popular.

Li Lu: Wesfarmers benefits from long-term consumption, urbanisation and productivity, but Australia is a finite market. The opportunity is compounding per-store economics and disciplined reinvestment, not unlimited TAM.